NervGen Pharma Corp
XTSX:NGEN

Watchlist Manager
NervGen Pharma Corp Logo
NervGen Pharma Corp
XTSX:NGEN
Watchlist
Price: 7.68 CAD 11.14% Market Closed
Market Cap: 564.9m CAD

Wall Street
Price Targets

NGEN Price Targets Summary
NervGen Pharma Corp

Wall Street analysts forecast NGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NGEN is 7.75 CAD with a low forecast of 5.05 CAD and a high forecast of 10.19 CAD.

Lowest
Price Target
5.05 CAD
34% Downside
Average
Price Target
7.75 CAD
1% Upside
Highest
Price Target
10.19 CAD
33% Upside
NervGen Pharma Corp Competitors:
Price Targets
002422
Sichuan Kelun Pharmaceutical Co Ltd
38% Upside
MEDCL
Medincell SA
43% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
24% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
44% Upside
600285
Henan Lingrui Pharmaceutical Co Ltd
36% Upside
000423
Dong-E-E-Jiao Co Ltd
58% Upside

Revenue
Forecast

Revenue Estimate
NervGen Pharma Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
NervGen Pharma Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss

Net Income
Forecast

Net Income Estimate
NervGen Pharma Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NGEN's stock price target?
Price Target
7.75 CAD

According to Wall Street analysts, the average 1-year price target for NGEN is 7.75 CAD with a low forecast of 5.05 CAD and a high forecast of 10.19 CAD.

Back to Top